If you’ve been researching medical weight loss, you’ve almost certainly seen two names come up again and again: semaglutide and tirzepatide. Both are prescription injections taken once a week, and both have helped many people lose a meaningful amount of weight. So what’s the real difference? This guide breaks down semaglutide vs tirzepatide in plain language: how each one works, what the research shows, common side effects and who may be a good candidate.
Only a clinician who knows your health history can tell you which option, if either, fits you. But understanding the basics will help you have a better conversation.
How These Medications Work
Both medications mimic hormones your gut naturally releases after you eat. These hormones signal fullness to the brain, slow how quickly the stomach empties and help the body manage blood sugar. The result for many people is smaller appetite, fewer cravings and less “food noise.”
Semaglutide
Semaglutide is a GLP-1 receptor agonist. It acts on one hormone pathway, GLP-1. It is the active ingredient in Wegovy, which is FDA-approved for chronic weight management, and Ozempic, which is approved for type 2 diabetes.
Tirzepatide
Tirzepatide acts on two pathways: GLP-1 and a second gut hormone called GIP. It is the active ingredient in Zepbound, approved for chronic weight management, and Mounjaro, approved for type 2 diabetes.
Semaglutide vs. Tirzepatide: Key Differences
- Mechanism: semaglutide targets GLP-1; tirzepatide targets both GLP-1 and GIP.
- Average weight loss in studies: in large clinical trials, people taking semaglutide 2.4 mg lost about 15% of their body weight on average over roughly 68 weeks, while people taking the highest doses of tirzepatide lost about 20% over 72 weeks. A head-to-head trial also found greater average weight loss with tirzepatide. Averages are not promises, and individual results vary widely.
- Dosing: both are once-weekly injections started at a low dose and increased gradually over several months to limit side effects.
- Experience and track record: semaglutide has been on the market longer, so there is more long-term data, including a large trial showing reduced risk of heart attack and stroke in adults with heart disease and excess weight.
- Cost and coverage: prices and insurance coverage vary and change often. Check with your insurance carrier about your specific plan.
Common Side Effects
The side effects of the two medications are similar. The most common are digestive: nausea, diarrhea, constipation, vomiting, heartburn and a feeling of fullness. These tend to be strongest when starting or increasing a dose and often ease over time. Eating smaller meals, slowing down and limiting greasy foods can help.
Less common but more serious risks include pancreatitis, gallbladder problems, kidney problems related to dehydration and low blood sugar in people who also take certain diabetes medications. Both carry a warning about a type of thyroid tumor seen in animal studies, so they are not used in people with a personal or family history of medullary thyroid cancer or multiple endocrine neoplasia type 2 (MEN 2). They should not be used during pregnancy. Tell your clinician right away about severe stomach pain, persistent vomiting or signs of an allergic reaction.
Who May Be a Candidate?
FDA-approved weight management versions of these medications are generally meant for adults who have:
- A body mass index (BMI) of 30 or higher, or
- A BMI of 27 or higher plus at least one weight-related condition, such as high blood pressure, type 2 diabetes, high cholesterol or sleep apnea
Your clinician will also review your medical history, current medications, family history and goals before recommending anything.
Medication Is One Part of the Plan
These medications work best alongside nutrition, physical activity, sleep and steady follow-up. Getting enough protein and doing strength training can help protect muscle while you lose weight. Research also shows that many people regain some weight after stopping, so it’s worth talking with your clinician about a long-term plan from the start. Our medical weight loss program is built around that kind of ongoing support.
Learn more about set point theory.
Getting Care by Telehealth With Sana Vida
Sana Vida Wellness Center is a virtual clinic. Your evaluation and follow-up visits happen by telehealth, so you can talk with a clinician from home or work. We see patients virtually across Texas, including San Antonio, through our telehealth program, as well as in Wyoming, Virginia, Florida, New Mexico, Arizona and Colorado. The one exception to virtual care is hormone pellet insertion, which is done in person at our San Antonio clinic for patients who choose pellets.
Care is led by Dr. P. John Schanen, DNP, APRN, FNP-C, ENP-C, a board-certified family and emergency nurse practitioner. Pricing is simple: a $99 consultation plus a $149 monthly membership per service line, with discounts when you combine more than one service line.
Frequently Asked Questions
Is tirzepatide better than semaglutide?
On average, studies have shown somewhat more weight loss with tirzepatide. “Better” depends on the person, though, including how well you tolerate the medication, your other health conditions, availability and cost. Your clinician can help you weigh those factors.
Can I switch from one to the other?
Sometimes. Switching is a decision to make with your clinician, who will choose the right starting dose and timing for you.
How quickly will I see results?
Many people notice a smaller appetite within the first few weeks, but weight loss usually builds gradually as the dose is increased over several months.
Take the Next Step
Curious whether a GLP-1 medication could be part of your plan? Book a virtual visit with Sana Vida Wellness Center to talk through your health history and goals with a clinician. You can also call us at (210) 879-4275 or email john@sanavidawellness.com.
This article is for educational purposes only and is not a substitute for personalized medical advice, diagnosis or treatment.
